1. Home > Latest Topics >

Question 14: The features of fluoloquinolones

20 June, 2018

question_14_5


LATEST TOPICS

Navigating antibiotic resistance in community-acquired pneumonia: Insights from Vietnam
29 October, 2024
Optimising antibiotic therapy: Insights on transitioning from intravenous to oral treatment for community-acquired pneumonia
27 September, 2024
Community-acquired pneumonia in Cambodia: Navigating the growing challenge of AMR
30 June, 2024
Managing Infectious Diseases in Emergency Medicine: A Specialist’s Approach
10 April, 2024
Advancing standardised diagnosis and treatment of acute infectious disease: Insights from an expert in theory–technique integration
08 April, 2024

RELATED ARTICLES

Fluoroquinolones in the management of hospital-acquired pneumonia
20 June, 2023
60-year development of quinolones (2): The clinical application of traditional classic quinolones and new quinolones
13 October, 2022
Standardized treatment of chronic obstructive pulmonary disease (COPD)
17 January, 2023
60-year development of quinolones: The clinical application of quinolones in urology
17 January, 2023
Pharmacokinetic and microbial susceptibility studies of sitafloxacin
10 February, 2023